Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Vaccinotoxinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1141-2022
Class II · Moderate risk

Tuberculinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1139-2022
Class II · Moderate risk

Syphilinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1138-2022
Class II · Moderate risk

Streptococcinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1137-2022
Class II · Moderate risk

Pyrogenium

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1136-2022
Class II · Moderate risk

Proteus

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1135-2022
Class II · Moderate risk

Pertussinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1134-2022
Class II · Moderate risk

Morbillinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1133-2022
Class II · Moderate risk

Medorrhinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1132-2022
Class II · Moderate risk

Influenzinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1131-2022
Class II · Moderate risk

Diphtherinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1130-2022
Class II · Moderate risk

Colibacillinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1129-2022
Class II · Moderate risk

Anthracinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1125-2022
Class II · Moderate risk

Zonisamide Capsules USP

CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.

Terminated Microbial contamination Direct Rx NDC 61919-775-90 D-0888-2022

Recalls by year